Background/aim: Methotrexate (MTX) is a folic acid antagonist that widely used to treat osteosarcoma, leukemia, breast cancer, and autoimmune inflammatory diseases. The most important concerns with MTX are its poor solubility high toxicity, particularly in liver cells. To enhance minimize we encapsulated niosomes investigated hepatotoxicity mechanisms using genetic biomarkers. Materials methods...